# FDA Inspection 1181766 - Washington Regional Transplant Community - October 13, 2022

Source: https://www.keypedia.com/records/fda_inspections/washington-regional-transplant-community/5b79baf0-e70e-45c7-a17f-3b05460f1929
Source feed: FDA_Inspections

> FDA Inspection 1181766 for Washington Regional Transplant Community on October 13, 2022. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1181766
- Company Name: Washington Regional Transplant Community
- Inspection Date: 2022-10-13
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1181766 - 2022-10-13](https://www.keypedia.com/records/fda_inspections/washington-regional-transplant-community/1b9f2eaf-df30-44fa-8e06-b5f5d8c86590)
- [FDA Inspection 1181766 - 2022-10-13](https://www.keypedia.com/records/fda_inspections/washington-regional-transplant-community/694c8ded-0414-4bc4-9c3a-6f00bf263e8b)
- [FDA Inspection 1084996 - 2019-03-19](https://www.keypedia.com/records/fda_inspections/washington-regional-transplant-community/c27b14bd-3b32-49cb-98df-ffb17d891588)
- [FDA Inspection 1003957 - 2017-01-31](https://www.keypedia.com/records/fda_inspections/washington-regional-transplant-community/3e399c3e-224f-4cea-8912-05d980a17a8c)
- [FDA Inspection 912243 - 2015-02-02](https://www.keypedia.com/records/fda_inspections/washington-regional-transplant-community/3edd4dd4-b3bd-41cd-b2a6-9ada973bc820)

Company: https://www.keypedia.com/companies/washington-regional-transplant-community/e4f12a4b-0b3a-4c63-af9a-1bf7cbaccbe3

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d